Sunder Biomedical Tech. , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow71.41
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Sunder Biomedical Tech. , Ltd. (4115.TWO) currently reports a P/E ratio of 71.41. That is above the sector sector average of 24.62. Use the charts on this page to explore Sunder Biomedical Tech. , Ltd.'s P/E ratio history and peer comparisons.
Sunder Biomedical Tech. , Ltd.'s P/E ratio of 71.41 is higher than the its sector sector average of 24.62. That is roughly 190.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Sunder Biomedical Tech. , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At 71.41, 4115.TWO can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 71.41, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 24.62. From there, open related valuation or income-statement pages for Sunder Biomedical Tech. , Ltd., and consider following 4115.TWO for alerts when major investors trade the stock.
